⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13088904 | 1.00 | — | — | |
| SCHEMBL5369505 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3934119 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL755298 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL3931726 | 0.96 | — | — | |
| SCHEMBL21921142 | 0.75 | — | — | |
| SCHEMBL586900 | 0.75 | — | — | |
| SCHEMBL11056284 | 0.73 | — | — | |
| SCHEMBL23776843 | 0.72 | — | — | |
| SCHEMBL10002484 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103958502-A | Quinazoline compounds as serine/threonine kinase inhibitors | ARRAY BIOPHARMA INC | 2014-07-30 | — | — | CN | claimed |
| CN-101193884-A | Tubulin inhibitor and process for its preparation | WYETH CORP (US) | 2008-06-04 | — | — | CN | claimed |
| US-20010003744-A1 | Therapeutic compounds | CHAMBERLAIN STANLEY DAWES (US) | 2001-06-14 | — | — | US | claimed |
| US-6077832-A | FOR THERAPY AND PROPHYLAXIS OF HERPES VIRUS INFECTION | GLAXO WELLCOME INC. (US) | 2000-06-20 | — | — | US | claimed |
| EP-0769017-B1 | THERAPEUTIC COMPOUNDS | WELLCOME FOUND (GB) | 2000-05-24 | — | — | EP | claimed |
| CN-1052010-C | Benzimidazole derivatives, method for the production thereof, use thereof and pharmaceutical preparations containing the same | WELLCOME FOUND (GB) | 2000-05-03 | — | — | CN | claimed |
| CN-1159194-A | Therapeutic compounds | WELLCOME FOUND (GB) | 1997-09-10 | — | — | CN | claimed |
| WO-1996001833-A1 | THERAPEUTIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-01-25 | — | — | WO | claimed |
| EP-4371987-B9 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS | GILEAD SCIENCES INC (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4371987-B1 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS | GILEAD SCIENCES INC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250270190-A1 | KIT INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2025-08-28 | — | — | US | disclosed |
| EP-4578451-A2 | COMPOUNDS AND COMPOSITIONS AS SPPL2A INHIBITORS | Novartis AG (CH) | 2025-07-02 | — | — | EP | disclosed |
| EP-4214210-B1 | COMPOUNDS AND COMPOSITIONS AS SPPL2A INHIBITORS | NOVARTIS AG (CH) | 2025-04-09 | — | — | EP | disclosed |
| US-12258346-B2 | Substituted 6-azabenzimidazole compounds | GILEAD SCIENCES, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| CN-1052010-C | Benzimidazole derivatives, method for the production thereof, use thereof and pharmaceutical preparations containing the same | WELLCOME FOUND (GB) | 2000-05-03 | — | — | CN | disclosed |
| US-5998605-A | Antiviral benzimidazole nucleoside analogues and method for their preparation | GLAXO WELLCOME INC. (US) | 1999-12-07 | — | — | US | disclosed |
| CN-1236616-A | Application of benzimidazole derivatives in preparing medicine | WELLCOME FOUND (GB) | 1999-12-01 | — | — | CN | disclosed |
| WO-1999033790-A1 | INSECTICIDAL FLUORO-SUBSTITUTED BENZOYLUREAS | NIHON BAYER AGROCHEM K.K. (DE) | 1999-07-08 | — | — | WO | disclosed |
| CN-1159194-A | Therapeutic compounds | WELLCOME FOUND (GB) | 1997-09-10 | — | — | CN | disclosed |
| WO-1996001833-A1 | THERAPEUTIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-01-25 | — | — | WO | disclosed |